A Phase 2/3 Open-Label, Single-Arm Trial to Evaluate the Safety and Activity of Eculizumab in Pediatric Patients with Relapsing Neuromyelitis Optica Spectrum Disorder
Administered By
Awarded By
Contributors
- Van Mater, Heather Ann Principal Investigator
Start/End
- November 30, 2020 - November 30, 2022